Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > One more look at the new 90 day optimized data

<< Previous

Bullboard Posts

Next >>

Comment by CancerSlayeron Apr 28, 2022 6:34pm

242 Views

Post# 34640563

RE:RE:RE:RE:One more look at the new 90 day optimized data

Forgot to mention: The duration of response is an equally important benchmark. I'd much rather have a "meaningful" delay in cancer progression (i.e. unchanged CIS) than a CR that has no lasting benefit. That 18 to 24 month data is no less important than the CR data. While we await the BTD, key Study II data remain an unknown. Still plenty of time before any serious/meaningful deals are discussed imo.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario